BridgeMD
Tests treatment safety and results for Colorectal Cancer
Official title Efficacy and Safety of Colorectal Anastomotic Leak Testing
ClinicalTrials.gov ID: NCT06865638
What this study is testing
- What it's testing
- To evaluate the effectiveness of the gastroscopy, air, and methylene blue (GAM) leak testing in reducing the incidence of postoperative anastomotic complications, especially anastomotic leakage, in patients with colorectal cancer. The primary outcomes included is the incidence of anastomotic complications (mainly anastomotic leak) within 30 days after surgery
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patients diagnosed with colorectal cancer by pathology and scheduled for surgical treatment who meet the surgical indications.
- Aged between 18 and 85 years.
- American Society of Anesthesiologists (ASA) physical status classification is I - III.
- The patient or his/her legal representative can understand and sign the informed consent form and is willing to cooperate throughout the study...
You likely can't join if
- Patients with preoperatively diagnosed anastomotic leak or other severe abdominal infections.
- Patients with severe cardiovascular and cerebrovascular diseases (such as recent myocardial infarction, unstable angina pectoris, severe heart...
- Patients with severely impaired liver and kidney function (liver function Child - Pugh classification C or above, creatinine clearance rate \< 30...
- Patients with coagulation disorders (such as platelet count \ 1.5, etc.) that cannot be corrected or are receiving anticoagulant therapy that cannot...
- Patients with a history of abdominal radiotherapy or multiple abdominal surgeries and severe abdominal adhesions that may affect the operation and...
- Patients with other malignant tumors who are receiving active anti-tumor treatment such as radiotherapy and chemotherapy.
See the full eligibility criteria
- Patients diagnosed with colorectal cancer by pathology and scheduled for surgical treatment who meet the surgical indications.
- Aged between 18 and 85 years.
- American Society of Anesthesiologists (ASA) physical status classification is I - III.
- The patient or his/her legal representative can understand and sign the informed consent form and is willing to cooperate throughout the study process.
- Patients with preoperatively diagnosed anastomotic leak or other severe abdominal infections.
- Patients with severe cardiovascular and cerebrovascular diseases (such as recent myocardial infarction, unstable angina pectoris, severe heart failure, acute cerebral infarction, etc.) who cannot tolerate surgery and...
- Patients with severely impaired liver and kidney function (liver function Child - Pugh classification C or above, creatinine clearance rate \< 30 ml/min).
- Patients with coagulation disorders (such as platelet count \ 1.5, etc.) that cannot be corrected or are receiving anticoagulant therapy that cannot be adjusted.
- Patients with a history of abdominal radiotherapy or multiple abdominal surgeries and severe abdominal adhesions that may affect the operation and detection procedures.
- Patients with other malignant tumors who are receiving active anti-tumor treatment such as radiotherapy and chemotherapy.
- Patients with mental illness or cognitive impairment who cannot cooperate with the study process and follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Nanchong, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanchong, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.